The Metastasis Prize

The prize (currently 12.000€) will be awarded to scientists who convincingly show that the proposed projects will generate a new opening in metastasis research. It must be clear from the proposal how the preliminary results obtained through the prize may enable the candidate to apply competitively for a research grant from national or international organizations.

Eligibility: We fund science performed in universities or not-for-profit organizations in the countries of the European Research Community (ERC; as defined by the EU) http://cordis.europa.eu/fp7/who_en.html#countries

Following the first prize assignment in 2013 we decided to award two prizes in 2015. We selected both an early stage (Junior Prize = until 6 years after PhD)  and a more advanced stage scientist (Senior Prize = until 12 years after PhD) as awardees of the Metastasis Prize.

2017, we awarded two Senior Prizes.

In 2019 our financial situation allowed us to award 3 prizes: one Junior prize and two Senior prizes

Metastasis Prize 2019

After the call for proposals in the beginning of 2019 we obtained 16 applications equally divided in 8 applications for a Junior prize and 8 applications for a Senior prize.

The board members made a preselection based on the most important criteria of our foundation: an innovative idea that requires preliminary evidence before the candidate can apply for a full research grant. The board judges how the preliminary data resulting from the Metastasis Prize will facilitate follow-up research and will contribute to success in grant applications to regular national and international funding agencies. 

The 3 or 4 most promising applications in both categories (Junior and Senior prizes) are next presented to a board of international experts to be ranked.